Two Smaller Companies Worthy of Your "Attention"

Zacks Nov 26 04:35

Elite Pharmaceuticals' Stock Up Despite Q2 Earnings Decline

Zacks Nov 19 00:15

Elite Pharmaceuticals Receives FDA Approval on Its NDA for ADHD Treatment

Seeking AlphaNov 18 21:47

ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 ended September 30, 2024 and Provides Conference Call Information

SECNov 15 05:56

ELITE PHARMACEUTICALS INC | 10-Q: Q2 2025 Earnings Report

SECNov 15 05:36 · Announcements

ELITE PHARMACEUTICALS INC (ELTP.US) will release its financial report after the market closes on November 14th.

$ELITE PHARMACEUTICALS INC(ELTP.US)$ will release its financial report after the market closes on November 14th. How was the performance before this? $ELITE PHARMACEUTICALS INC(ELTP.US)$ had revenue of $18.803063 million, net income of $0.615773 million, and earnings per share of $0.000572 in 2025/Q1. In 2024/Q2, revenue was $14.157185 million, and net income was $14.934601 million.

Futu NewsNov 11 16:45